Mannose‐Decorated Co‐Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing

Abstract

Butyrate is a key bacterial metabolite that plays an important and complex role in modulation of immunity and maintenance of epithelial barriers. Its translation to clinic has been limited by poor bioavailability, pungent smell, and the need for high doses, and effective delivery strategies have yet to realize clinical potential. Here we report a novel polymeric delivery platform for tunable and sustainable release of butyrate consisting of a methacrylamide backbone with butyryl ester or phenyl ester side chains as well as mannosyl side chains, which is also applicable to other therapeutically‐relevant metabolites. We explore this platform's utility in the treatment of non‐healing diabetic wounds. This butyrate‐containing material modulated immune cell activation in vitro and induced striking changes in the milieu of soluble cytokine and chemokine signals present within the diabetic wound microenvironment in vivo. This novel therapy shows efficacy in the treatment of non‐healing wounds through the modulation of the soluble signals present within the wound, and importantly accommodates the critical temporal regulation associated with the wound healing process. Currently, the few therapies to address non‐healing wounds demonstrate limited efficacy. Our novel platform is positioned to address this large unmet clinical need and improve the closure of otherwise non‐healing wounds.This article is protected by copyright. All rights reserved

Therapeutic synthetic and natural materials for immunoengineering

“…Materials such as these have often been employed to improve outcomes diabetic wound healing, including fibrous mats releasing pioglitazone hydrochloride, 365 stimuli-responsive materials releasing metformin, 366 or soluble polymeric materials releasing butyrate. 367…”